SSSushma B. Singh

Sushma B. Singh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sushma B. Singh has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Targeting Parallel Topology of G-Quadruplex Structures by Indole- Fused Quindoline Scaffolds

    by Satendra Kumar, Sushree Prangya Priyadarshinee Pany, Sruthi Sudhakar, Sushma B. Singh, Chaitra S. Todankar, P. I. Pradeepkumar

    Preferential stabilization of G-quadruplex (G4) structures using small-molecule ligands has emerged as an effective approach to develop anticancer drugs. Herein, we report the synthesis of three indole-fused quindoline derivatives with varying lengths of side chains (InqEt1, InqEt2, and InqPr2) as selective ligands for promoter G4 structures. The ligands stabilize the parallel topology of c-MYC and c-KIT1 promoter G4 DNAs over telomeric and duplex DNAs, as evident from the circular dichroism melting and polymerase stop-assay experiments. The lead ligand, InqPr2, downregulates the gene expression of c-MYC and c-KIT in HeLa and HepG2 cells, respectively, leading to apoptotic cell death. Molecular modeling and dynamics studies support the 2:1 binding stoichiometry revealed from the Job plot analysis and show the ligand's structural features that enable the preferential binding to the parallel G4 structures over other topologies. Our studies show that indole-fused quindoline derivatives can be harnessed as new molecular scaffolds for selective targeting of parallel G4 topologies.


  • Stabilization and fluorescence light-up of G-quadruplex nucleic acids using indolyl-quinolinium based probes

    by Annyesha Biswas, Sushma B. Singh, Chaitra S. Todankar, Sruthi Sudhakar, Sushree Prangya Priyadarshinee Pany, P. I. Pradeepkumar

    G-Quadruplexes (G4s) are four-stranded motifs formed by G-rich nucleic acid sequences. These structures harbor significant biological importance as they are involved in telomere maintenance, transcription, and translation. Owing to their dynamic and polymorphic nature, G4 structures relevant for therapeutic applications need to be stabilized by small-molecule ligands. Some of these ligands turn on fluorescence upon binding to G4 structures, which provides a powerful detection platform for G4 structures. Herein, we report the synthesis of fluorescent ligands based on the indolyl-quinolinium moiety to specifically stabilize G4 structures and sense DNA. CD titration and melting experiments have shown that the lead ligand induces the formation of parallel G4 with preferential stabilization of the c-MYC and c-KIT1 promoter G4s over the telomeric, h-RAS1 G4, and duplex DNA. Fluorimetric titration data revealed fluorescence enhancement when these ligands interact with G4 DNA structures. The fluorescence lifetime experiment of the ligand with different DNAs revealed three excited state lifetimes (ns), which indicates more than one binding site. MD studies showed that the ligand exhibits 3 : 1 stoichiometry of binding with c-MYC G4 DNA and revealed the unique structural features, which impart selectivity toward parallel topology. The ligand was found to have low cytotoxicity and exhibited preferential staining of DNA over RNA. Collectively, the results presented here offer avenues to harness indolyl-quinolinium scaffolds for sensing and selective stabilization of G4 structures.


  • Acetylcholinesterase and Aβ Aggregation Inhibition by Heterometallic Ruthenium(II)–Platinum(II) Polypyridyl Complexes

    by Nilima A. Vyas, Sushma B. Singh, Avinash S. Kumbhar, Dnyanesh S. Ranade, Gulshan R. Walke, Prasad P. Kulkarni, Vinod Jani, Uddhavesh B. Sonavane, Rajendra R. Joshi, Srikanth Rapole

    Two heteronuclear ruthenium(II)–platinum(II) complexes [Ru(bpy)2(BPIMBp)PtCl2]2+ (3) and [Ru(phen)2(BPIMBp)PtCl2]2+ (4), where bpy = 2,2′-bipyridine, phen = 1,10-phenanthroline, and BPIMBp = 1,4′-bis[(2-pyridin-2-yl)-1H-imidazol-1-ylmethyl]-1,1′-biphenyl, have been designed and synthesized from their mononuclear precursors [Ru(bpy)2(BPIMBp)]2+ (1) and [Ru(phen)2(BPIMBp)]2+ (2) as multitarget molecules for Alzheimer’s disease (AD). The inclusion of the cis-PtCl2 moiety facilitates the covalent interaction of Ru(II) polypyridyl complexes with amyloid β (Aβ) peptide. These multifunctional complexes act as inhibitors of acetylcholinesterase (AChE), Aβ aggregation, and Cu-induced oxidative stress and protect neuronal cells against Aβ-toxicity. The study highlights the design of metal based anti-Alzheimer’s disease (AD) systems.


  • Honeycomb‐like Ordered Assembly of DNA Induced by Flexible Binuclear Ruthenium(II)–Polypyridyl Complexes

    by Sushma B. Singh, Avinash S. Kumbhar, Ayesha Khan

    A series of binuclear ruthenium(II)–polypyridyl complexes of the type [Ru2(N‐N)4(BPIMBp)]4+, in which N‐N is 2,2′‐bipyridine (bpy; 1), 1,10‐phenanthroline (phen; 2), dipyrido[3,2‐d:2′,3‐f] quinoxaline (dpq; 3), dipyrido[3,2‐a:2′,3′‐c] phenanzine (dppz; 4), and 1,4′‐bis[(2‐pyridin‐2‐yl)‐1H‐imidazol‐1‐yl)methyl]‐1,1′‐biphenyl (BPIMBp) is a bridging ligand, have been synthesized and characterized. These complexes are charged (4+) cations and flexible due to the −CH2 group of the bridging ligand and possess terminal ligands with variable intercalative abilities. The interaction of complexes 1–4 with calf thymus DNA (CT‐DNA) was explored by using UV/Vis absorption spectroscopy, steady‐state emission, emission quenching with K4[Fe(CN)6], ethidium bromide displacement assay, Hoechst displacement assay, and viscosity measurements and revealed a groove‐binding mode for all the complexes through a spacer and an intercalative mode for complexes 3 and 4. A decrease in the viscosity of DNA revealed bending and coiling of DNA, an initial step toward aggregation. Interestingly, a distinctive honeycomb‐like ordered assembly of the DNA–complex species was visualized by fluorescence microscopy in the solution state. The use of SEM and AFM confirmed the disordered self‐organization of the DNA–complex adduct on evaporation of the solvent. The small orderly nanosized DNA aggregates were confirmed by means of circular dichroism, dynamic light scattering (DLS), and TEM. These complexes are moderately cytotoxic against three different cell lines, namely, MCF‐7, HeLa, and HL‐60.


  • Open Access

    Antiproliferative activity of ruthenium(ii) arene complexes with mono- and bidentate pyridine-based ligands

    by Stefan Richter, Sushma Singh, Dijana Draca, Anup Kate, Anupa Kumbhar, Avinash S. Kumbhar, Danijela Maksimovic-Ivanic, Sanja Mijatovic, Peter Lönnecke, Evamarie Hey-Hawkins

    The antitumour activity of RuII arene complexes with N-donor ligands is realised through inhibition of cell division accompanied by caspase-dependent apoptosis.


  • Copper( ii ) mixed-ligand polypyridyl complexes with doxycycline – structures and biological evaluation

    by Olufunso O. Abosede, Nilima A. Vyas, Sushma B. Singh, Avinash S. Kumbhar, Anup Kate, Anupa A. Kumbhar, Ayesha Khan, Andrea Erxleben, Peter Smith, Carmen de Kock, et al.

    Structures and biological evaluation of Cu( ii ) mixed-ligand polypyridyl complexes with doxycycline of the type [Cu(doxycycline)(L)(H 2 O) 2 ](NO 3 ) 2 , L = 2,2′-bipyridine (bpy, 1 ), 1,10-phenanthroline (phen, 2 ), dipyrido[3,2- d :2′,3′- f ]quinoxaline (dpq, 3 ) and dipyrido[3,2- a :2′,3′- c ]phenazine (dppz, 4 ).